newsfilter
← Latest News
GlobeNewswire·

Amryt Supports Global EB Awareness Week 2022

Amryt Supports Global EB Awareness Week 2022 DUBLIN, Ireland, and Boston MA, October 24, 2022, Amryt (NASDAQ:AMYT, AIM: AMYT)), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing